vs
Side-by-side financial comparison of reAlpha Tech Corp. (AIRE) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.
PLUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($1.4M vs $895.3K, roughly 1.5× reAlpha Tech Corp.). PLUS THERAPEUTICS, INC. runs the higher net margin — -417.9% vs -541.6%, a 123.7% gap on every dollar of revenue. On growth, reAlpha Tech Corp. posted the faster year-over-year revenue change (70.1% vs -3.2%). PLUS THERAPEUTICS, INC. produced more free cash flow last quarter ($-6.3M vs $-11.3M). Over the past eight quarters, reAlpha Tech Corp.'s revenue compounded faster (562.1% CAGR vs -9.7%).
reAlpha Tech Corp is a proptech firm that leverages artificial intelligence to identify, acquire, and operate high-yield short-term residential rental properties primarily across the United States. It provides tech-powered property management solutions to enhance guest experiences and maximize returns for individual and institutional real estate investors.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
AIRE vs PSTV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $895.3K | $1.4M |
| Net Profit | $-4.8M | $-5.7M |
| Gross Margin | 62.7% | — |
| Operating Margin | -507.8% | -420.0% |
| Net Margin | -541.6% | -417.9% |
| Revenue YoY | 70.1% | -3.2% |
| Net Profit YoY | 76.9% | -46.4% |
| EPS (diluted) | $-0.02 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $895.3K | $1.4M | ||
| Q3 25 | $1.4M | $1.4M | ||
| Q2 25 | $1.3M | $1.4M | ||
| Q1 25 | $925.6K | $1.1M | ||
| Q4 24 | $526.4K | $1.4M | ||
| Q3 24 | $339.2K | $1.5M | ||
| Q2 24 | $62.4K | $1.3M | ||
| Q1 24 | $20.4K | $1.7M |
| Q4 25 | $-4.8M | $-5.7M | ||
| Q3 25 | $-5.8M | $-4.4M | ||
| Q2 25 | $-4.1M | $5.2M | ||
| Q1 25 | $-2.8M | $-17.4M | ||
| Q4 24 | $-21.0M | $-3.9M | ||
| Q3 24 | $-2.1M | $-2.9M | ||
| Q2 24 | $-1.5M | $-2.9M | ||
| Q1 24 | $-1.4M | $-3.3M |
| Q4 25 | 62.7% | — | ||
| Q3 25 | 51.9% | — | ||
| Q2 25 | 49.6% | — | ||
| Q1 25 | 56.0% | — | ||
| Q4 24 | 71.1% | — | ||
| Q3 24 | 66.6% | — | ||
| Q2 24 | 70.7% | — | ||
| Q1 24 | 10.7% | — |
| Q4 25 | -507.8% | -420.0% | ||
| Q3 25 | -342.4% | -320.8% | ||
| Q2 25 | -326.5% | -110.6% | ||
| Q1 25 | -261.7% | -333.9% | ||
| Q4 24 | -524.6% | -276.2% | ||
| Q3 24 | -479.1% | -260.9% | ||
| Q2 24 | -1939.6% | -289.1% | ||
| Q1 24 | -6397.0% | -196.7% |
| Q4 25 | -541.6% | -417.9% | ||
| Q3 25 | -400.1% | -316.6% | ||
| Q2 25 | -328.3% | 370.6% | ||
| Q1 25 | -307.9% | -1643.2% | ||
| Q4 24 | -3994.4% | -276.4% | ||
| Q3 24 | -618.6% | -197.4% | ||
| Q2 24 | -2370.9% | -229.9% | ||
| Q1 24 | -6946.9% | -194.5% |
| Q4 25 | $-0.02 | $0.95 | ||
| Q3 25 | $-0.07 | $-0.04 | ||
| Q2 25 | $-0.08 | $-0.01 | ||
| Q1 25 | $-0.06 | $-1.19 | ||
| Q4 24 | $-0.47 | $-0.51 | ||
| Q3 24 | $-0.05 | $-0.37 | ||
| Q2 24 | $-0.03 | $-0.71 | ||
| Q1 24 | $-0.03 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.8M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $11.5M | $4.0M |
| Total Assets | $21.7M | $16.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.8M | $8.6M | ||
| Q3 25 | — | $16.6M | ||
| Q2 25 | $587.3K | $6.9M | ||
| Q1 25 | $1.2M | $9.9M | ||
| Q4 24 | $3.1M | $3.6M | ||
| Q3 24 | $7.1M | $4.8M | ||
| Q2 24 | $3.7M | $8.4M | ||
| Q1 24 | $4.8M | $3.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $152.9K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $241.1K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $11.5M | $4.0M | ||
| Q3 25 | $10.9M | $5.1M | ||
| Q2 25 | $-1.1M | $3.0M | ||
| Q1 25 | $-972.3K | $-23.6M | ||
| Q4 24 | $1.6M | $-8.9M | ||
| Q3 24 | $22.5M | $-5.2M | ||
| Q2 24 | $22.2M | $-7.6M | ||
| Q1 24 | $23.3M | $-4.8M |
| Q4 25 | $21.7M | $16.3M | ||
| Q3 25 | $19.7M | $18.7M | ||
| Q2 25 | $15.5M | $10.3M | ||
| Q1 25 | $18.5M | $12.1M | ||
| Q4 24 | $12.0M | $6.6M | ||
| Q3 24 | $34.2M | $7.0M | ||
| Q2 24 | $24.6M | $11.2M | ||
| Q1 24 | $25.4M | $5.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.3M | $-6.3M |
| Free Cash FlowOCF − Capex | $-11.3M | $-6.3M |
| FCF MarginFCF / Revenue | -1262.7% | -459.9% |
| Capex IntensityCapex / Revenue | 4.8% | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-20.2M | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.3M | $-6.3M | ||
| Q3 25 | $-4.2M | $-2.5M | ||
| Q2 25 | $-2.3M | $-5.8M | ||
| Q1 25 | $-2.3M | $-6.2M | ||
| Q4 24 | $-6.0M | $-1.2M | ||
| Q3 24 | $-1.3M | $-3.7M | ||
| Q2 24 | $-1.0M | $-1.1M | ||
| Q1 24 | $-1.5M | $-4.5M |
| Q4 25 | $-11.3M | $-6.3M | ||
| Q3 25 | $-4.3M | $-2.6M | ||
| Q2 25 | $-2.3M | $-5.8M | ||
| Q1 25 | $-2.3M | $-6.2M | ||
| Q4 24 | $-6.1M | $-1.2M | ||
| Q3 24 | $-1.3M | $-3.7M | ||
| Q2 24 | — | $-1.2M | ||
| Q1 24 | — | $-4.6M |
| Q4 25 | -1262.7% | -459.9% | ||
| Q3 25 | -294.1% | -184.3% | ||
| Q2 25 | -187.5% | -417.6% | ||
| Q1 25 | -246.4% | -583.1% | ||
| Q4 24 | -1150.2% | -86.5% | ||
| Q3 24 | -372.2% | -253.7% | ||
| Q2 24 | — | -96.2% | ||
| Q1 24 | — | -271.5% |
| Q4 25 | 4.8% | 2.2% | ||
| Q3 25 | 0.4% | 1.9% | ||
| Q2 25 | 1.1% | 0.5% | ||
| Q1 25 | 1.5% | 0.3% | ||
| Q4 24 | 2.4% | 0.8% | ||
| Q3 24 | 2.2% | 1.0% | ||
| Q2 24 | — | 6.3% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.13× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
